219 related articles for article (PubMed ID: 16278833)
1. Normal lymphocytes from leukemic samples as an internal quality control for fluorescence intensity in immunophenotyping of acute leukemias.
Ratei R; Karawajew L; Lacombe F; Jagoda K; Del Poeta G; Kraan J; De Santiago M; Kappelmayer J; Björklund E; Ludwig WD; Gratama J; Orfao A;
Cytometry B Clin Cytom; 2006 Jan; 70(1):1-9. PubMed ID: 16278833
[TBL] [Abstract][Full Text] [Related]
2. Comparative analysis of different permeabilization methods for the flow cytometry measurement of cytoplasmic myeloperoxidase and lysozyme in normal and leukemic cells.
Lanza F; Latorraca A; Moretti S; Castagnari B; Ferrari L; Castoldi G
Cytometry; 1997 Jun; 30(3):134-44. PubMed ID: 9222099
[TBL] [Abstract][Full Text] [Related]
3. [Immunophenotyping of acute leukemias: diagnostic and pronostic utility in Abidjan, Côte d'Ivoire].
Inwoley KA; Sawadogo D; Mizero L; Salou M; Karim N; Sangaré A
Bull Soc Pathol Exot; 2004; 97(5):319-22. PubMed ID: 15787262
[TBL] [Abstract][Full Text] [Related]
4. [Detection of minimal residual disease in B lineage acute lymphoblastic leukemia by 4-color flow cytometry].
Liu YR; Wang H; Chang Y; Cheng YF; Fu JY; Zhang LP; Liu GL; Chen SS
Zhonghua Xue Ye Xue Za Zhi; 2005 Jun; 26(6):327-31. PubMed ID: 16185473
[TBL] [Abstract][Full Text] [Related]
5. New methodologic approaches for immunophenotyping acute leukemias.
Basso G; Buldini B; De Zen L; Orfao A
Haematologica; 2001 Jul; 86(7):675-92. PubMed ID: 11454522
[TBL] [Abstract][Full Text] [Related]
6. Multiparametric analysis of normal and postchemotherapy bone marrow: Implication for the detection of leukemia-associated immunophenotypes.
Olaru D; Campos L; Flandrin P; Nadal N; Duval A; Chautard S; Guyotat D
Cytometry B Clin Cytom; 2008 Jan; 74(1):17-24. PubMed ID: 18061947
[TBL] [Abstract][Full Text] [Related]
7. Overexpression of CD49f in precursor B-cell acute lymphoblastic leukemia: potential usefulness in minimal residual disease detection.
DiGiuseppe JA; Fuller SG; Borowitz MJ
Cytometry B Clin Cytom; 2009 Mar; 76(2):150-5. PubMed ID: 18831072
[TBL] [Abstract][Full Text] [Related]
8. Flow cytometric immunophenotyping analysis of patterns of antigen expression in non-Hodgkin's B cell lymphoma in samples obtained from different anatomic sites.
Gervasi F; Lo Verso R; Giambanco C; Cardinale G; Tomaselli C; Pagnucco G
Ann N Y Acad Sci; 2004 Dec; 1028():457-62. PubMed ID: 15650271
[TBL] [Abstract][Full Text] [Related]
9. Discriminant function analysis as decision support system for the diagnosis of acute leukemia with a minimal four color screening panel and multiparameter flow cytometry immunophenotyping.
Ratei R; Karawajew L; Lacombe F; Jagoda K; Del Poeta G; Kraan J; De Santiago M; Kappelmayer J; Björklund E; Ludwig WD; Gratama JW; Orfao A;
Leukemia; 2007 Jun; 21(6):1204-11. PubMed ID: 17410192
[TBL] [Abstract][Full Text] [Related]
10. Phenotypic quantitative features of patients with acute myeloid leukemia.
Pereira FG; Metze K; Costa FP; Lima CS; Lorand-Metze I
Neoplasma; 2006; 53(2):155-60. PubMed ID: 16575472
[TBL] [Abstract][Full Text] [Related]
11. [Bone marrow immunophenotypes of 112 cases of lymphoid system malignant diseases].
Ling JY; Sun XF; Yan SL; He LR; Zhen ZJ; Xia Y
Ai Zheng; 2007 Apr; 26(4):418-22. PubMed ID: 17430665
[TBL] [Abstract][Full Text] [Related]
12. Comparison of mRNA abundance quantified by gene expression profiling and percentage of positive cells using immunophenotyping for diagnostic antigens in acute and chronic leukemias.
Kern W; Kohlmann A; Schoch C; Schnittger S; Haferlach T
Cancer; 2006 Nov; 107(10):2401-7. PubMed ID: 17041886
[TBL] [Abstract][Full Text] [Related]
13. [Analysis of immunophenotype and leukemia associated immunophenotype in 610 patients with acute myeloid leukemia].
Liu YR; Wang YZ; Chen SS; Chang Y; Fu JY; Li LD; Wang H; Yu H; Jiang B; Huang XJ
Zhonghua Xue Ye Xue Za Zhi; 2007 Nov; 28(11):731-6. PubMed ID: 18457262
[TBL] [Abstract][Full Text] [Related]
14. Quantitative immunocytofluorometry--new parameters for the definition of leukemia cells.
Babusíková O; Glasová M; Stasáková J; Kusenda J; Koníková E
Neoplasma; 1997; 44(6):348-55. PubMed ID: 9605006
[TBL] [Abstract][Full Text] [Related]
15. Fluorescence-intensity multiplexing: simultaneous seven-marker, two-color immunophenotyping using flow cytometry.
Bradford JA; Buller G; Suter M; Ignatius M; Beechem JM
Cytometry A; 2004 Oct; 61(2):142-52. PubMed ID: 15382027
[TBL] [Abstract][Full Text] [Related]
16. Aberrant expression of T-cell markers in acute myeloid leukemia.
Lewis RE; Cruse JM; Sanders CM; Webb RN; Suggs JL
Exp Mol Pathol; 2007 Dec; 83(3):462-3. PubMed ID: 17927977
[TBL] [Abstract][Full Text] [Related]
17. [Immunophenotyping of eighty six children with acute lymphoblastic leukemia by three-color flow cytometry].
Wan S; Gong W; Sun X; Xu J; Tian D
Zhonghua Xue Ye Xue Za Zhi; 2002 Feb; 23(2):83-6. PubMed ID: 12015077
[TBL] [Abstract][Full Text] [Related]
18. Long-term stabilized blood samples as controls for flow cytometric HLA-B27 screening: a feasibility study.
Levering WH; Wind H; Granger V; Sintnicolaas K; Hooijkaas H; Reilly JT; Gratama JW; Barnett D
Cytometry B Clin Cytom; 2008 May; 74(3):169-81. PubMed ID: 18200592
[TBL] [Abstract][Full Text] [Related]
19. Increased myeloid precursors in regenerating bone marrow; implications for detection of minimal residual disease in acute myeloid leukemia.
Zeleznikova T; Stevulova L; Kovarikova A; Babusikova O
Neoplasma; 2007; 54(6):471-7. PubMed ID: 17949229
[TBL] [Abstract][Full Text] [Related]
20. Nationwide quality control trial on lymphocyte immunophenotyping and flow cytometer performance in Italy.
Brando B; Sommaruga E
Cytometry; 1993; 14(3):294-306. PubMed ID: 8472606
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
